Compare CLW & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLW | SMTI |
|---|---|---|
| Founded | 1926 | 1982 |
| Country | United States | United States |
| Employees | 3710 | N/A |
| Industry | Paper | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.1M | 313.5M |
| IPO Year | 2008 | 2008 |
| Metric | CLW | SMTI |
|---|---|---|
| Price | $20.33 | $34.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $20.33 | ★ $34.00 |
| AVG Volume (30 Days) | 122.9K | ★ 329.8K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,555,400,000.00 | $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | $4.16 | $12.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 12.42 | ★ 32.47 |
| 52 Week Low | $11.73 | $16.05 |
| 52 Week High | $23.59 | $35.70 |
| Indicator | CLW | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 78.00 |
| Support Level | $20.28 | $33.99 |
| Resistance Level | $20.80 | N/A |
| Average True Range (ATR) | 0.86 | 0.25 |
| MACD | -0.26 | -0.30 |
| Stochastic Oscillator | 46.65 | 97.16 |
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.